Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.9980
-0.0720 (-6.73%)
Jan 21, 2026, 3:46 PM CET
Neola Medical AB Revenue
Neola Medical AB had revenue of 1.80M SEK in the quarter ending September 30, 2025, with 3.81% growth. This brings the company's revenue in the last twelve months to 8.35M, down -24.36% year-over-year. In the year 2024, Neola Medical AB had annual revenue of 10.12M with 2.97% growth.
Revenue (ttm)
8.35M
Revenue Growth
-24.36%
P/S Ratio
9.99
Revenue / Employee
1.04M
Employees
8
Market Cap
83.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.12M | 292.00K | 2.97% |
| Dec 31, 2023 | 9.83M | 82.00K | 0.84% |
| Dec 31, 2022 | 9.74M | -1.38M | -12.43% |
| Dec 31, 2021 | 11.13M | 8.20M | 280.64% |
| Dec 31, 2020 | 2.92M | 103.00K | 3.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |